PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.78
Bid: 42.66
Ask: 42.76
Change: -0.38 (-0.88%)
Spread: 0.10 (0.234%)
Open: 42.16
High: 43.04
Low: 42.16
Prev. Close: 43.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Jul 2020 07:00

RNS Number : 1660S
Assura PLC
07 July 2020

7 July 2020

Assura plc

Trading Update

For the first quarter ending 30 June 2020

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter ending 30 June 2020.

Jonathan Murphy, CEO, said:

"We've had an active first quarter, as we continued to deliver strategic and financial progress across all areas of the business, despite these uncertain times for the UK. Our business model remains resilient and robust, as demonstrated by normal patterns of recent rent collections and all our development sites being active in line with social distancing guidelines.

"Our social purpose - to create outstanding primary care properties that sit at the heart of our local communities - has never been more important than it is today, and we are making good progress with our recently launched sixbysix social impact strategy.

"As lockdown restrictions gradually ease, we are working closely with our GP partners to ensure we best support the NHS and respond to evolving market needs as part of the 'new normal'. Primary care will play a crucial role as the UK seeks to rebuild and recover from the COVID-19 crisis and we are engaging with Government to ensure that it remains a key area of investment going forward."

Operational update

Safety and wellbeing of our colleagues, tenants and patients our top priority

Ongoing discussions with our tenants and the NHS on how our buildings can best support the evolving needs of GPs and patients as we gradually move out of the lockdown

All construction sites active with appropriate social distancing measures in place

June quarter rents being received in line with normal patterns

Active first quarter

Strong portfolio of 565 properties with current annualised rent roll of 拢110.2 million

Developments at Stafford and Netherfield completed (combined cost 拢11.9 million) - the latter is on track for a BREEAM rating of "Excellent", incorporating a number of sustainable elements including electric vehicle charging points, photovoltaic panels and an air source heat pump

Five schemes progressed to on-site, including Stourport in Worcestershire which is part funded by NHS England's Estates and Technology Transformation Fund ("ETTF")

Seven acquisitions completed for combined 拢35 million

Portfolio of 20 assets disposed for 拢17 million, as disclosed in our year end results in May

Two lease regears completed (拢0.3 million of existing rent)

One capital asset enhancement project completed and three currently on site (combined spend 拢0.6 million)

Strong pipeline for growth

Currently on-site with 18 developments with a total cost of 拢95 million

Immediate development pipeline totalling 拢60 million: schemes which we expect to be on site within 12 months

Immediate acquisitions pipeline stands at 拢51 million, which we would normally expect to complete in three-six months

45 lease re-gears covering 拢5.6 million of existing rent roll in the current pipeline

Pipeline of 21 capital asset enhancement projects (projected spend 拢15 million) over the next two years

Robust balance sheet

At 30 June 2020 gross debt stood at 拢767 million with undrawn facilities of 拢300 million

As announced with our year end results in May, the maturity of the revolving credit facility has been extended to November 2025, with the facility reducing from 拢300 million to 拢225 million with effect from May 2021

ENDS

For further information, please contact:

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

Tel: 01925 420 680

Email: Investor@assura.co.uk

Finsbury:

Gordon Simpson

James Thompson

Tel: 0207 251 3801

Email: Assura@Finsbury.com

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at 拢2,139 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TSTFLFESDDIRIII
Date   Source Headline
7th Dec 202110:55 amRNSDirector/PDMR Shareholding
2nd Dec 20218:57 amRNSNotice of Dividend
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20217:00 amRNSCapital Markets Webinar
18th Nov 20219:42 amRNSHolding(s) in Company
16th Nov 20215:22 pmRNSHolding(s) in Company
15th Nov 20219:52 amRNSDirector/PDMR Shareholding
11th Nov 20214:32 pmRNSResult of Placing
11th Nov 20217:01 amRNSPrimaryBid offer
11th Nov 20217:00 amRNSProposed equity placing of new ordinary shares
11th Nov 20217:00 amRNSInterim Results 2021
9th Nov 202112:07 pmRNSDirector/PDMR Shareholding
8th Nov 20214:04 pmRNSHolding(s) in Company
5th Nov 20217:00 amRNSInvestor Presentation
29th Oct 20217:00 amRNSNotice of Interim Results
29th Oct 20217:00 amRNSTotal Voting Rights
27th Oct 20213:51 pmRNSHolding(s) in Company
25th Oct 20217:58 amRNSIssue of Consideration Shares
19th Oct 20214:15 pmRNSDirector/PDMR Shareholding
13th Oct 20212:31 pmRNSAppointment of Joint Corporate Broker
11th Oct 20217:00 amRNSScrip Dividend Declaration
7th Oct 20219:14 amRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSTrading Update
4th Oct 20212:58 pmRNSHolding(s) in Company
21st Sep 20217:00 amRNSHolding(s) in Company
20th Sep 20214:44 pmRNSHolding(s) in Company
17th Sep 20219:33 amRNSScrip Calculation Price
16th Sep 20214:27 pmRNSHolding(s) in Company
14th Sep 20214:15 pmRNSHolding(s) in Company
13th Sep 20219:08 amRNSHolding(s) in Company
7th Sep 20219:02 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Dividend
6th Aug 20219:24 amRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSReduction of RCF
28th Jul 20214:23 pmRNSHolding(s) in Company
26th Jul 20215:30 pmRNSHolding(s) in Company
26th Jul 20218:57 amRNSHolding(s) in Company
20th Jul 20211:56 pmRNSDirector/PDMR Shareholding
15th Jul 20219:56 amRNSExercise of Nil Cost Options under PSP
12th Jul 20211:00 pmRNSScrip Dividend Declaration
8th Jul 202112:20 pmRNSDirector/PDMR Shareholding
8th Jul 202110:08 amRNSDirector/PDMR Shareholding
6th Jul 20212:15 pmRNSResult of AGM
6th Jul 202111:39 amRNSAdditional Listing
6th Jul 20217:00 amRNSTrading Update
28th Jun 20211:02 pmRNSHolding(s) in Company
23rd Jun 20214:01 pmRNSPricing of £300m Sustainability Bond
22nd Jun 20215:05 pmRNSHolding(s) in Company
17th Jun 20219:52 amRNSScrip Calculation Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.